nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—Adenosine triphosphate—ABCG1—atherosclerosis	0.0146	0.417	CrCbGaD
Fludarabine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.0142	0.5	CbGdCrCtD
Fludarabine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.0142	0.5	CbGdCrCtD
Fludarabine—Adenosine triphosphate—HSPA1B—atherosclerosis	0.0111	0.316	CrCbGaD
Fludarabine—Hearing impaired—Pravastatin—atherosclerosis	0.00745	0.00809	CcSEcCtD
Fludarabine—Blood uric acid increased—Niacin—atherosclerosis	0.00733	0.00797	CcSEcCtD
Fludarabine—Hepatic failure—Lovastatin—atherosclerosis	0.00677	0.00736	CcSEcCtD
Fludarabine—Hepatic failure—Ezetimibe—atherosclerosis	0.00664	0.00722	CcSEcCtD
Fludarabine—Oesophagitis—Niacin—atherosclerosis	0.00658	0.00715	CcSEcCtD
Fludarabine—Sleep disorder—Simvastatin—atherosclerosis	0.00658	0.00714	CcSEcCtD
Fludarabine—Hepatic failure—Simvastatin—atherosclerosis	0.00634	0.00688	CcSEcCtD
Fludarabine—Bronchitis—Rosuvastatin—atherosclerosis	0.00597	0.00648	CcSEcCtD
Fludarabine—Sleep disorder—Pravastatin—atherosclerosis	0.00595	0.00646	CcSEcCtD
Fludarabine—Deafness—Pravastatin—atherosclerosis	0.00575	0.00625	CcSEcCtD
Fludarabine—Hepatic failure—Pravastatin—atherosclerosis	0.00573	0.00622	CcSEcCtD
Fludarabine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00551	0.00599	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00548	0.00595	CcSEcCtD
Fludarabine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00543	0.00589	CcSEcCtD
Fludarabine—Adenosine triphosphate—ABCA1—atherosclerosis	0.00541	0.154	CrCbGaD
Fludarabine—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00538	0.00584	CcSEcCtD
Fludarabine—Haematuria—Rosuvastatin—atherosclerosis	0.00528	0.00573	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00523	0.00568	CcSEcCtD
Fludarabine—Sinusitis—Rosuvastatin—atherosclerosis	0.00519	0.00564	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00513	0.00557	CcSEcCtD
Fludarabine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00493	0.00536	CcSEcCtD
Fludarabine—Liver function test abnormal—Niacin—atherosclerosis	0.00483	0.00524	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.0048	0.00521	CcSEcCtD
Fludarabine—Liver function test abnormal—Pravastatin—atherosclerosis	0.00475	0.00516	CcSEcCtD
Fludarabine—Bronchitis—Simvastatin—atherosclerosis	0.00473	0.00514	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00465	0.00505	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00464	0.00503	CcSEcCtD
Fludarabine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.0046	0.00499	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00457	0.00497	CcSEcCtD
Fludarabine—Urinary tract infection—Lovastatin—atherosclerosis	0.00456	0.00495	CcSEcCtD
Fludarabine—Dysphagia—Niacin—atherosclerosis	0.00452	0.00491	CcSEcCtD
Fludarabine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00451	0.0049	CcSEcCtD
Fludarabine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00444	0.00482	CcSEcCtD
Fludarabine—Angina pectoris—Niacin—atherosclerosis	0.0044	0.00478	CcSEcCtD
Fludarabine—Sinusitis—Lovastatin—atherosclerosis	0.0044	0.00478	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00435	0.00473	CcSEcCtD
Fludarabine—Bronchitis—Niacin—atherosclerosis	0.00435	0.00472	CcSEcCtD
Fludarabine—Angina pectoris—Pravastatin—atherosclerosis	0.00433	0.00471	CcSEcCtD
Fludarabine—Sweating increased—Pravastatin—atherosclerosis	0.00433	0.00471	CcSEcCtD
Fludarabine—Sinusitis—Ezetimibe—atherosclerosis	0.00432	0.00469	CcSEcCtD
Fludarabine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.0043	0.00467	CcSEcCtD
Fludarabine—Dysuria—Pravastatin—atherosclerosis	0.00416	0.00452	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00414	0.00449	CcSEcCtD
Fludarabine—Sinusitis—Simvastatin—atherosclerosis	0.00412	0.00447	CcSEcCtD
Fludarabine—Pharyngitis—Ezetimibe—atherosclerosis	0.0041	0.00445	CcSEcCtD
Fludarabine—Erythema multiforme—Lovastatin—atherosclerosis	0.00398	0.00432	CcSEcCtD
Fludarabine—Adenosine triphosphate—AKT1—atherosclerosis	0.00397	0.113	CrCbGaD
Fludarabine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00393	0.00427	CcSEcCtD
Fludarabine—Stomatitis—Niacin—atherosclerosis	0.00393	0.00427	CcSEcCtD
Fludarabine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00391	0.00425	CcSEcCtD
Fludarabine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00391	0.00424	CcSEcCtD
Fludarabine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00389	0.00422	CcSEcCtD
Fludarabine—Myocardial infarction—Pravastatin—atherosclerosis	0.00389	0.00422	CcSEcCtD
Fludarabine—Urinary tract infection—Pravastatin—atherosclerosis	0.00386	0.00419	CcSEcCtD
Fludarabine—Chills—Lovastatin—atherosclerosis	0.00378	0.0041	CcSEcCtD
Fludarabine—Cough—Rosuvastatin—atherosclerosis	0.00377	0.0041	CcSEcCtD
Fludarabine—Erythema multiforme—Simvastatin—atherosclerosis	0.00372	0.00405	CcSEcCtD
Fludarabine—Sinusitis—Pravastatin—atherosclerosis	0.00372	0.00404	CcSEcCtD
Fludarabine—Alopecia—Lovastatin—atherosclerosis	0.00372	0.00404	CcSEcCtD
Fludarabine—Arthralgia—Rosuvastatin—atherosclerosis	0.00368	0.004	CcSEcCtD
Fludarabine—Myalgia—Rosuvastatin—atherosclerosis	0.00368	0.004	CcSEcCtD
Fludarabine—Alopecia—Ezetimibe—atherosclerosis	0.00365	0.00396	CcSEcCtD
Fludarabine—Haemoglobin—Niacin—atherosclerosis	0.00364	0.00395	CcSEcCtD
Fludarabine—Haemorrhage—Niacin—atherosclerosis	0.00362	0.00393	CcSEcCtD
Fludarabine—Hypoaesthesia—Niacin—atherosclerosis	0.0036	0.00391	CcSEcCtD
Fludarabine—Malnutrition—Ezetimibe—atherosclerosis	0.0036	0.00391	CcSEcCtD
Fludarabine—Confusional state—Rosuvastatin—atherosclerosis	0.00356	0.00387	CcSEcCtD
Fludarabine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00354	0.00385	CcSEcCtD
Fludarabine—Pharyngitis—Pravastatin—atherosclerosis	0.00353	0.00384	CcSEcCtD
Fludarabine—Chills—Simvastatin—atherosclerosis	0.00353	0.00384	CcSEcCtD
Fludarabine—Infection—Rosuvastatin—atherosclerosis	0.00351	0.00381	CcSEcCtD
Fludarabine—Visual impairment—Niacin—atherosclerosis	0.00349	0.00379	CcSEcCtD
Fludarabine—Alopecia—Simvastatin—atherosclerosis	0.00348	0.00378	CcSEcCtD
Fludarabine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00346	0.00376	CcSEcCtD
Fludarabine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00346	0.00375	CcSEcCtD
Fludarabine—Visual impairment—Pravastatin—atherosclerosis	0.00343	0.00373	CcSEcCtD
Fludarabine—Ill-defined disorder—Lovastatin—atherosclerosis	0.0034	0.00369	CcSEcCtD
Fludarabine—Erythema multiforme—Pravastatin—atherosclerosis	0.00337	0.00366	CcSEcCtD
Fludarabine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00334	0.00362	CcSEcCtD
Fludarabine—Anaemia—Ezetimibe—atherosclerosis	0.00332	0.00361	CcSEcCtD
Fludarabine—Malaise—Lovastatin—atherosclerosis	0.00331	0.00359	CcSEcCtD
Fludarabine—Leukopenia—Lovastatin—atherosclerosis	0.00328	0.00356	CcSEcCtD
Fludarabine—Chills—Niacin—atherosclerosis	0.00325	0.00352	CcSEcCtD
Fludarabine—Malaise—Ezetimibe—atherosclerosis	0.00324	0.00352	CcSEcCtD
Fludarabine—Arrhythmia—Niacin—atherosclerosis	0.00323	0.00351	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00322	0.00349	CcSEcCtD
Fludarabine—Alopecia—Niacin—atherosclerosis	0.0032	0.00347	CcSEcCtD
Fludarabine—Chills—Pravastatin—atherosclerosis	0.0032	0.00347	CcSEcCtD
Fludarabine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00318	0.00346	CcSEcCtD
Fludarabine—Arrhythmia—Pravastatin—atherosclerosis	0.00318	0.00346	CcSEcCtD
Fludarabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00317	0.00344	CcSEcCtD
Fludarabine—Anaemia—Simvastatin—atherosclerosis	0.00317	0.00344	CcSEcCtD
Fludarabine—Malnutrition—Niacin—atherosclerosis	0.00315	0.00342	CcSEcCtD
Fludarabine—Alopecia—Pravastatin—atherosclerosis	0.00315	0.00342	CcSEcCtD
Fludarabine—Cough—Ezetimibe—atherosclerosis	0.00314	0.00341	CcSEcCtD
Fludarabine—Myalgia—Lovastatin—atherosclerosis	0.00312	0.00339	CcSEcCtD
Fludarabine—Arthralgia—Lovastatin—atherosclerosis	0.00312	0.00339	CcSEcCtD
Fludarabine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00311	0.00338	CcSEcCtD
Fludarabine—Malaise—Simvastatin—atherosclerosis	0.00309	0.00336	CcSEcCtD
Fludarabine—Discomfort—Lovastatin—atherosclerosis	0.00308	0.00335	CcSEcCtD
Fludarabine—Leukopenia—Simvastatin—atherosclerosis	0.00307	0.00333	CcSEcCtD
Fludarabine—Myalgia—Ezetimibe—atherosclerosis	0.00306	0.00332	CcSEcCtD
Fludarabine—Arthralgia—Ezetimibe—atherosclerosis	0.00306	0.00332	CcSEcCtD
Fludarabine—Discomfort—Ezetimibe—atherosclerosis	0.00302	0.00329	CcSEcCtD
Fludarabine—Constipation—Rosuvastatin—atherosclerosis	0.00302	0.00328	CcSEcCtD
Fludarabine—Pain—Rosuvastatin—atherosclerosis	0.00302	0.00328	CcSEcCtD
Fludarabine—Confusional state—Lovastatin—atherosclerosis	0.00302	0.00328	CcSEcCtD
Fludarabine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00299	0.00325	CcSEcCtD
Fludarabine—Infection—Lovastatin—atherosclerosis	0.00297	0.00323	CcSEcCtD
Fludarabine—Confusional state—Ezetimibe—atherosclerosis	0.00296	0.00321	CcSEcCtD
Fludarabine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00293	0.00319	CcSEcCtD
Fludarabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00293	0.00318	CcSEcCtD
Fludarabine—Arthralgia—Simvastatin—atherosclerosis	0.00292	0.00317	CcSEcCtD
Fludarabine—Myalgia—Simvastatin—atherosclerosis	0.00292	0.00317	CcSEcCtD
Fludarabine—Infection—Ezetimibe—atherosclerosis	0.00292	0.00317	CcSEcCtD
Fludarabine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00291	0.00316	CcSEcCtD
Fludarabine—Discomfort—Simvastatin—atherosclerosis	0.00288	0.00313	CcSEcCtD
Fludarabine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00288	0.00313	CcSEcCtD
Fludarabine—Ill-defined disorder—Pravastatin—atherosclerosis	0.00288	0.00312	CcSEcCtD
Fludarabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00287	0.00312	CcSEcCtD
Fludarabine—Anaemia—Pravastatin—atherosclerosis	0.00287	0.00311	CcSEcCtD
Fludarabine—Anorexia—Lovastatin—atherosclerosis	0.00285	0.0031	CcSEcCtD
Fludarabine—Confusional state—Simvastatin—atherosclerosis	0.00282	0.00306	CcSEcCtD
Fludarabine—Leukopenia—Niacin—atherosclerosis	0.00282	0.00306	CcSEcCtD
Fludarabine—Anaphylactic shock—Simvastatin—atherosclerosis	0.0028	0.00304	CcSEcCtD
Fludarabine—Oedema—Simvastatin—atherosclerosis	0.0028	0.00304	CcSEcCtD
Fludarabine—Malaise—Pravastatin—atherosclerosis	0.0028	0.00304	CcSEcCtD
Fludarabine—Infection—Simvastatin—atherosclerosis	0.00278	0.00302	CcSEcCtD
Fludarabine—Leukopenia—Pravastatin—atherosclerosis	0.00277	0.00301	CcSEcCtD
Fludarabine—Cough—Niacin—atherosclerosis	0.00275	0.00298	CcSEcCtD
Fludarabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00274	0.00298	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00273	0.00296	CcSEcCtD
Fludarabine—Cough—Pravastatin—atherosclerosis	0.00271	0.00294	CcSEcCtD
Fludarabine—Paraesthesia—Lovastatin—atherosclerosis	0.00269	0.00292	CcSEcCtD
Fludarabine—Arthralgia—Niacin—atherosclerosis	0.00268	0.00291	CcSEcCtD
Fludarabine—Myalgia—Niacin—atherosclerosis	0.00268	0.00291	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00267	0.0029	CcSEcCtD
Fludarabine—Anorexia—Simvastatin—atherosclerosis	0.00267	0.0029	CcSEcCtD
Fludarabine—Dyspnoea—Lovastatin—atherosclerosis	0.00267	0.0029	CcSEcCtD
Fludarabine—Myalgia—Pravastatin—atherosclerosis	0.00264	0.00287	CcSEcCtD
Fludarabine—Arthralgia—Pravastatin—atherosclerosis	0.00264	0.00287	CcSEcCtD
Fludarabine—Paraesthesia—Ezetimibe—atherosclerosis	0.00264	0.00286	CcSEcCtD
Fludarabine—Dyspepsia—Lovastatin—atherosclerosis	0.00263	0.00286	CcSEcCtD
Fludarabine—Dyspnoea—Ezetimibe—atherosclerosis	0.00262	0.00284	CcSEcCtD
Fludarabine—Discomfort—Pravastatin—atherosclerosis	0.00261	0.00283	CcSEcCtD
Fludarabine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0026	0.00283	CcSEcCtD
Fludarabine—Decreased appetite—Lovastatin—atherosclerosis	0.0026	0.00282	CcSEcCtD
Fludarabine—Dyspepsia—Ezetimibe—atherosclerosis	0.00258	0.00281	CcSEcCtD
Fludarabine—Fatigue—Lovastatin—atherosclerosis	0.00258	0.0028	CcSEcCtD
Fludarabine—Anaphylactic shock—Niacin—atherosclerosis	0.00257	0.00279	CcSEcCtD
Fludarabine—Oedema—Niacin—atherosclerosis	0.00257	0.00279	CcSEcCtD
Fludarabine—Constipation—Lovastatin—atherosclerosis	0.00256	0.00278	CcSEcCtD
Fludarabine—Pain—Lovastatin—atherosclerosis	0.00256	0.00278	CcSEcCtD
Fludarabine—Confusional state—Pravastatin—atherosclerosis	0.00255	0.00277	CcSEcCtD
Fludarabine—Decreased appetite—Ezetimibe—atherosclerosis	0.00255	0.00277	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00255	0.00277	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00253	0.00275	CcSEcCtD
Fludarabine—Asthenia—Rosuvastatin—atherosclerosis	0.00253	0.00275	CcSEcCtD
Fludarabine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00253	0.00275	CcSEcCtD
Fludarabine—Oedema—Pravastatin—atherosclerosis	0.00253	0.00275	CcSEcCtD
Fludarabine—Fatigue—Ezetimibe—atherosclerosis	0.00253	0.00275	CcSEcCtD
Fludarabine—Infection—Pravastatin—atherosclerosis	0.00251	0.00273	CcSEcCtD
Fludarabine—Paraesthesia—Simvastatin—atherosclerosis	0.00251	0.00273	CcSEcCtD
Fludarabine—Pain—Ezetimibe—atherosclerosis	0.00251	0.00273	CcSEcCtD
Fludarabine—Constipation—Ezetimibe—atherosclerosis	0.00251	0.00273	CcSEcCtD
Fludarabine—Pruritus—Rosuvastatin—atherosclerosis	0.0025	0.00271	CcSEcCtD
Fludarabine—Dyspnoea—Simvastatin—atherosclerosis	0.0025	0.00271	CcSEcCtD
Fludarabine—Hyperhidrosis—Niacin—atherosclerosis	0.00248	0.0027	CcSEcCtD
Fludarabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00248	0.00269	CcSEcCtD
Fludarabine—Feeling abnormal—Lovastatin—atherosclerosis	0.00247	0.00268	CcSEcCtD
Fludarabine—Dyspepsia—Simvastatin—atherosclerosis	0.00246	0.00268	CcSEcCtD
Fludarabine—Anorexia—Niacin—atherosclerosis	0.00245	0.00266	CcSEcCtD
Fludarabine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00245	0.00266	CcSEcCtD
Fludarabine—Decreased appetite—Simvastatin—atherosclerosis	0.00243	0.00264	CcSEcCtD
Fludarabine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00242	0.00263	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00242	0.00262	CcSEcCtD
Fludarabine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00242	0.00262	CcSEcCtD
Fludarabine—Fatigue—Simvastatin—atherosclerosis	0.00241	0.00262	CcSEcCtD
Fludarabine—Anorexia—Pravastatin—atherosclerosis	0.00241	0.00262	CcSEcCtD
Fludarabine—Pain—Simvastatin—atherosclerosis	0.00239	0.0026	CcSEcCtD
Fludarabine—Constipation—Simvastatin—atherosclerosis	0.00239	0.0026	CcSEcCtD
Fludarabine—Body temperature increased—Lovastatin—atherosclerosis	0.00237	0.00257	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00234	0.00254	CcSEcCtD
Fludarabine—Body temperature increased—Ezetimibe—atherosclerosis	0.00232	0.00252	CcSEcCtD
Fludarabine—Paraesthesia—Niacin—atherosclerosis	0.00231	0.00251	CcSEcCtD
Fludarabine—Feeling abnormal—Simvastatin—atherosclerosis	0.00231	0.0025	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00231	0.0025	CcSEcCtD
Fludarabine—Dyspnoea—Niacin—atherosclerosis	0.00229	0.00249	CcSEcCtD
Fludarabine—Paraesthesia—Pravastatin—atherosclerosis	0.00227	0.00247	CcSEcCtD
Fludarabine—Dyspepsia—Niacin—atherosclerosis	0.00226	0.00246	CcSEcCtD
Fludarabine—Dyspnoea—Pravastatin—atherosclerosis	0.00226	0.00245	CcSEcCtD
Fludarabine—Decreased appetite—Niacin—atherosclerosis	0.00223	0.00243	CcSEcCtD
Fludarabine—Dyspepsia—Pravastatin—atherosclerosis	0.00223	0.00242	CcSEcCtD
Fludarabine—Rash—Rosuvastatin—atherosclerosis	0.00223	0.00242	CcSEcCtD
Fludarabine—Dermatitis—Rosuvastatin—atherosclerosis	0.00222	0.00242	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00222	0.00241	CcSEcCtD
Fludarabine—Body temperature increased—Simvastatin—atherosclerosis	0.00221	0.0024	CcSEcCtD
Fludarabine—Headache—Rosuvastatin—atherosclerosis	0.00221	0.0024	CcSEcCtD
Fludarabine—Hypersensitivity—Lovastatin—atherosclerosis	0.0022	0.00239	CcSEcCtD
Fludarabine—Decreased appetite—Pravastatin—atherosclerosis	0.0022	0.00239	CcSEcCtD
Fludarabine—Pain—Niacin—atherosclerosis	0.0022	0.00239	CcSEcCtD
Fludarabine—Fatigue—Pravastatin—atherosclerosis	0.00218	0.00237	CcSEcCtD
Fludarabine—Pain—Pravastatin—atherosclerosis	0.00216	0.00235	CcSEcCtD
Fludarabine—Constipation—Pravastatin—atherosclerosis	0.00216	0.00235	CcSEcCtD
Fludarabine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00216	0.00235	CcSEcCtD
Fludarabine—Asthenia—Lovastatin—atherosclerosis	0.00215	0.00233	CcSEcCtD
Fludarabine—Pruritus—Lovastatin—atherosclerosis	0.00212	0.0023	CcSEcCtD
Fludarabine—Asthenia—Ezetimibe—atherosclerosis	0.00211	0.00229	CcSEcCtD
Fludarabine—Nausea—Rosuvastatin—atherosclerosis	0.0021	0.00228	CcSEcCtD
Fludarabine—Feeling abnormal—Pravastatin—atherosclerosis	0.00208	0.00226	CcSEcCtD
Fludarabine—Pruritus—Ezetimibe—atherosclerosis	0.00208	0.00226	CcSEcCtD
Fludarabine—Hypersensitivity—Simvastatin—atherosclerosis	0.00206	0.00224	CcSEcCtD
Fludarabine—Diarrhoea—Lovastatin—atherosclerosis	0.00205	0.00222	CcSEcCtD
Fludarabine—Body temperature increased—Niacin—atherosclerosis	0.00203	0.00221	CcSEcCtD
Fludarabine—Asthenia—Simvastatin—atherosclerosis	0.00201	0.00218	CcSEcCtD
Fludarabine—Diarrhoea—Ezetimibe—atherosclerosis	0.00201	0.00218	CcSEcCtD
Fludarabine—Body temperature increased—Pravastatin—atherosclerosis	0.002	0.00217	CcSEcCtD
Fludarabine—Pruritus—Simvastatin—atherosclerosis	0.00198	0.00215	CcSEcCtD
Fludarabine—Diarrhoea—Simvastatin—atherosclerosis	0.00191	0.00208	CcSEcCtD
Fludarabine—Vomiting—Lovastatin—atherosclerosis	0.0019	0.00207	CcSEcCtD
Fludarabine—Hypersensitivity—Niacin—atherosclerosis	0.00189	0.00206	CcSEcCtD
Fludarabine—Rash—Lovastatin—atherosclerosis	0.00189	0.00205	CcSEcCtD
Fludarabine—Dermatitis—Lovastatin—atherosclerosis	0.00188	0.00205	CcSEcCtD
Fludarabine—Headache—Lovastatin—atherosclerosis	0.00187	0.00204	CcSEcCtD
Fludarabine—Vomiting—Ezetimibe—atherosclerosis	0.00187	0.00203	CcSEcCtD
Fludarabine—Hypersensitivity—Pravastatin—atherosclerosis	0.00186	0.00202	CcSEcCtD
Fludarabine—Rash—Ezetimibe—atherosclerosis	0.00185	0.00201	CcSEcCtD
Fludarabine—Dermatitis—Ezetimibe—atherosclerosis	0.00185	0.00201	CcSEcCtD
Fludarabine—Asthenia—Niacin—atherosclerosis	0.00184	0.002	CcSEcCtD
Fludarabine—Headache—Ezetimibe—atherosclerosis	0.00184	0.002	CcSEcCtD
Fludarabine—Pruritus—Niacin—atherosclerosis	0.00182	0.00197	CcSEcCtD
Fludarabine—Asthenia—Pravastatin—atherosclerosis	0.00182	0.00197	CcSEcCtD
Fludarabine—Pruritus—Pravastatin—atherosclerosis	0.00179	0.00194	CcSEcCtD
Fludarabine—Vomiting—Simvastatin—atherosclerosis	0.00178	0.00193	CcSEcCtD
Fludarabine—Nausea—Lovastatin—atherosclerosis	0.00178	0.00193	CcSEcCtD
Fludarabine—Rash—Simvastatin—atherosclerosis	0.00176	0.00192	CcSEcCtD
Fludarabine—Dermatitis—Simvastatin—atherosclerosis	0.00176	0.00191	CcSEcCtD
Fludarabine—Diarrhoea—Niacin—atherosclerosis	0.00176	0.00191	CcSEcCtD
Fludarabine—Headache—Simvastatin—atherosclerosis	0.00175	0.0019	CcSEcCtD
Fludarabine—Nausea—Ezetimibe—atherosclerosis	0.00174	0.00189	CcSEcCtD
Fludarabine—Diarrhoea—Pravastatin—atherosclerosis	0.00173	0.00188	CcSEcCtD
Fludarabine—Nausea—Simvastatin—atherosclerosis	0.00166	0.00181	CcSEcCtD
Fludarabine—Vomiting—Niacin—atherosclerosis	0.00163	0.00177	CcSEcCtD
Fludarabine—Rash—Niacin—atherosclerosis	0.00162	0.00176	CcSEcCtD
Fludarabine—Dermatitis—Niacin—atherosclerosis	0.00162	0.00176	CcSEcCtD
Fludarabine—Headache—Niacin—atherosclerosis	0.00161	0.00175	CcSEcCtD
Fludarabine—Vomiting—Pravastatin—atherosclerosis	0.00161	0.00175	CcSEcCtD
Fludarabine—Rash—Pravastatin—atherosclerosis	0.0016	0.00173	CcSEcCtD
Fludarabine—Dermatitis—Pravastatin—atherosclerosis	0.00159	0.00173	CcSEcCtD
Fludarabine—Headache—Pravastatin—atherosclerosis	0.00159	0.00172	CcSEcCtD
Fludarabine—Nausea—Niacin—atherosclerosis	0.00153	0.00166	CcSEcCtD
Fludarabine—Nausea—Pravastatin—atherosclerosis	0.0015	0.00163	CcSEcCtD
Fludarabine—RRM1—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.000648	0.0411	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.000592	0.0376	CbGpPWpGaD
Fludarabine—DCK—Purine metabolism—GPX1—atherosclerosis	0.00054	0.0343	CbGpPWpGaD
Fludarabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—atherosclerosis	0.000518	0.0329	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—SIRT1—atherosclerosis	0.000405	0.0257	CbGpPWpGaD
Fludarabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—atherosclerosis	0.000386	0.0245	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—GPX1—atherosclerosis	0.000353	0.0224	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000309	0.0196	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000307	0.0195	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000296	0.0188	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—GPX1—atherosclerosis	0.000271	0.0172	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—SERPINE1—atherosclerosis	0.000251	0.0159	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000234	0.0149	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000233	0.0148	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00023	0.0146	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—SIRT1—atherosclerosis	0.000228	0.0145	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000221	0.014	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000212	0.0135	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000191	0.0121	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000188	0.0119	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000184	0.0117	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000175	0.0111	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000173	0.011	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000167	0.0106	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000158	0.0101	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000142	0.00904	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000141	0.00898	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—SERPINE1—atherosclerosis	0.000141	0.00897	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LDLRAP1—atherosclerosis	0.000139	0.00881	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000137	0.0087	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000136	0.00864	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000131	0.00834	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLTP—atherosclerosis	0.00013	0.00828	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000122	0.00777	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00012	0.00761	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LTA4H—atherosclerosis	0.000113	0.00718	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCG8—atherosclerosis	0.000113	0.00718	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000111	0.00706	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LDLRAP1—atherosclerosis	0.000107	0.00678	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000106	0.00671	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000102	0.00647	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000101	0.00644	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000101	0.00644	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLTP—atherosclerosis	0.0001	0.00637	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	9.42e-05	0.00598	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.4e-05	0.00597	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—APOB—atherosclerosis	9.01e-05	0.00572	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCG1—atherosclerosis	8.94e-05	0.00568	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	8.94e-05	0.00568	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	8.8e-05	0.00559	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCG8—atherosclerosis	8.7e-05	0.00553	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LTA4H—atherosclerosis	8.7e-05	0.00553	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	8.65e-05	0.0055	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—FABP4—atherosclerosis	8.4e-05	0.00534	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LCAT—atherosclerosis	8.4e-05	0.00534	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	8.28e-05	0.00526	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOA4—atherosclerosis	8.25e-05	0.00524	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP7A1—atherosclerosis	8.1e-05	0.00515	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	7.99e-05	0.00507	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	7.96e-05	0.00506	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PLG—atherosclerosis	7.6e-05	0.00483	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.6e-05	0.00483	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	7.56e-05	0.0048	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP27A1—atherosclerosis	7.49e-05	0.00476	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	7.33e-05	0.00466	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.13e-05	0.00453	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALOX5AP—atherosclerosis	7.1e-05	0.00451	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALOX15—atherosclerosis	7.1e-05	0.00451	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOA2—atherosclerosis	7.1e-05	0.00451	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLA2G2A—atherosclerosis	7.1e-05	0.00451	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCG5—atherosclerosis	7.01e-05	0.00446	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.01e-05	0.00445	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	6.89e-05	0.00438	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCG1—atherosclerosis	6.88e-05	0.00437	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	6.85e-05	0.00435	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LPA—atherosclerosis	6.77e-05	0.0043	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—APOB—atherosclerosis	6.72e-05	0.00427	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—BGN—atherosclerosis	6.56e-05	0.00417	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOA5—atherosclerosis	6.49e-05	0.00413	CbGpPWpGaD
Fludarabine—DCK—Metabolism—FABP4—atherosclerosis	6.47e-05	0.00411	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LCAT—atherosclerosis	6.47e-05	0.00411	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOA4—atherosclerosis	6.35e-05	0.00403	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLA2G1B—atherosclerosis	6.25e-05	0.00397	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP7A1—atherosclerosis	6.24e-05	0.00396	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALOX5—atherosclerosis	6.04e-05	0.00384	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP27A1—atherosclerosis	5.76e-05	0.00366	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	5.71e-05	0.00363	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.66e-05	0.0036	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—atherosclerosis	5.65e-05	0.00359	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALOX15—atherosclerosis	5.46e-05	0.00347	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALOX5AP—atherosclerosis	5.46e-05	0.00347	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLA2G2A—atherosclerosis	5.46e-05	0.00347	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOA2—atherosclerosis	5.46e-05	0.00347	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NAMPT—atherosclerosis	5.42e-05	0.00344	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCG5—atherosclerosis	5.4e-05	0.00343	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LIPC—atherosclerosis	5.38e-05	0.00342	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOC3—atherosclerosis	5.35e-05	0.0034	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LDLR—atherosclerosis	5.32e-05	0.00338	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.31e-05	0.00338	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LPA—atherosclerosis	5.21e-05	0.00331	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CETP—atherosclerosis	5.19e-05	0.0033	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	5.1e-05	0.00324	CbGpPWpGaD
Fludarabine—DCK—Metabolism—BGN—atherosclerosis	5.05e-05	0.00321	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOA5—atherosclerosis	5e-05	0.00317	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SCARB1—atherosclerosis	4.97e-05	0.00316	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	4.96e-05	0.00315	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.87e-05	0.0031	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLA2G1B—atherosclerosis	4.81e-05	0.00306	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMGCR—atherosclerosis	4.7e-05	0.00298	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALOX5—atherosclerosis	4.65e-05	0.00295	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.5e-05	0.00286	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.26e-05	0.0027	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.21e-05	0.00267	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCA1—atherosclerosis	4.19e-05	0.00266	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NAMPT—atherosclerosis	4.17e-05	0.00265	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LIPC—atherosclerosis	4.14e-05	0.00263	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.13e-05	0.00262	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOC3—atherosclerosis	4.12e-05	0.00261	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LDLR—atherosclerosis	4.09e-05	0.0026	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CETP—atherosclerosis	4e-05	0.00254	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.86e-05	0.00245	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SCARB1—atherosclerosis	3.83e-05	0.00243	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HMGCR—atherosclerosis	3.61e-05	0.0023	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMOX1—atherosclerosis	3.59e-05	0.00228	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOB—atherosclerosis	3.44e-05	0.00218	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM1—atherosclerosis	3.35e-05	0.00213	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LPL—atherosclerosis	3.28e-05	0.00209	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCA1—atherosclerosis	3.22e-05	0.00205	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GPX1—atherosclerosis	3.2e-05	0.00204	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CD36—atherosclerosis	3.12e-05	0.00198	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—atherosclerosis	2.96e-05	0.00188	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARA—atherosclerosis	2.9e-05	0.00184	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.87e-05	0.00182	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AGT—atherosclerosis	2.81e-05	0.00178	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HMOX1—atherosclerosis	2.76e-05	0.00176	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	2.76e-05	0.00175	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOE—atherosclerosis	2.75e-05	0.00175	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CAV1—atherosclerosis	2.73e-05	0.00173	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOA1—atherosclerosis	2.72e-05	0.00173	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOB—atherosclerosis	2.65e-05	0.00168	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM1—atherosclerosis	2.57e-05	0.00164	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LPL—atherosclerosis	2.53e-05	0.00161	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CG—atherosclerosis	2.48e-05	0.00158	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPX1—atherosclerosis	2.47e-05	0.00157	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CD36—atherosclerosis	2.4e-05	0.00153	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—atherosclerosis	2.4e-05	0.00152	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—INS—atherosclerosis	2.35e-05	0.00149	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—atherosclerosis	2.28e-05	0.00145	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARA—atherosclerosis	2.23e-05	0.00142	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AGT—atherosclerosis	2.16e-05	0.00137	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—atherosclerosis	2.16e-05	0.00137	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOE—atherosclerosis	2.12e-05	0.00135	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CAV1—atherosclerosis	2.1e-05	0.00133	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOA1—atherosclerosis	2.09e-05	0.00133	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NOS3—atherosclerosis	2.06e-05	0.00131	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK3—atherosclerosis	2.06e-05	0.00131	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CG—atherosclerosis	1.91e-05	0.00121	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—atherosclerosis	1.89e-05	0.0012	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—atherosclerosis	1.85e-05	0.00117	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK3—atherosclerosis	1.84e-05	0.00117	CbGpPWpGaD
Fludarabine—DCK—Metabolism—INS—atherosclerosis	1.81e-05	0.00115	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALB—atherosclerosis	1.66e-05	0.00105	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NOS3—atherosclerosis	1.59e-05	0.00101	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—atherosclerosis	1.45e-05	0.000922	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—atherosclerosis	9.48e-06	0.000602	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—atherosclerosis	7.3e-06	0.000463	CbGpPWpGaD
